Table 2.
Antibiotic susceptibility and the presence of ESBL genes in E.coli strains with FOM MIC ≥ 8 μg/mL.
| Strains | MIC (μg/mL) | ESBLagene | ||||
|---|---|---|---|---|---|---|
| Fosfomycin (≥128)b |
Levofloxacin (≥4)b |
Gentamicin (≥8)b |
Imipenem (≥2)b |
Ceftazidime (≥8)b |
||
| SRE257 | 1024∗ | ≤0.125 | 1 | 0.125 | 0.125 | — |
| SRE91 | 128# | 32∗ | 4 | 0.25 | 0.125 | — |
| SRE49 | 128# | 16∗ | 2 | 0.125 | 0.25 | — |
| SRE54 | 64 | ≥64∗ | ≥64∗ | 0.125 | 2 | CTX-M14 |
| SRE237 | 64 | ≤0.125 | 4 | 0.125 | 0.125 | — |
| SRE29 | 32 | 16∗ | ≥64∗ | 0.125 | 0.125 | — |
| SRE252 | 32 | 0.5 | 2 | 0.125 | 0.125 | — |
| SRE280 | 32 | ≤0.125 | 8∗ | 0.5 | 0.125 | — |
| SRE18 | 16 | 32∗ | 2 | 0.125 | 2 | CTX-M2 |
| SRE253 | 8 | ≤0.125 | 4 | 0.5 | 0.125 | — |
aESBL: extended spectrum β-lactamase.
bBreakpoints (μg/mL) are according to CLSI.
∗Resistant.
#Intermediate.